Annual SGA
$113.69 M
+$15.29 M+15.53%
December 31, 2024
Summary
- As of March 13, 2025, KRYS annual SGA is $113.69 million, with the most recent change of +$15.29 million (+15.53%) on December 31, 2024.
- During the last 3 years, KRYS annual SGA has risen by +$73.30 million (+181.46%).
- KRYS annual SGA is now at all-time high.
Performance
KRYS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$31.29 M
+$2.58 M+8.97%
December 31, 2024
Summary
- As of March 13, 2025, KRYS quarterly SGA is $31.29 million, with the most recent change of +$2.58 million (+8.97%) on December 31, 2024.
- Over the past year, KRYS quarterly SGA has increased by +$5.23 million (+20.07%).
- KRYS quarterly SGA is now at all-time high.
Performance
KRYS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$929.04 M
+$89.16 M+8.76%
December 31, 2024
Summary
- As of March 13, 2025, KRYS TTM SGA is -$929.04 million, with the most recent change of +$89.16 million (+8.76%) on December 31, 2024.
- Over the past year, KRYS TTM SGA has dropped by -$1.03 billion (-1025.12%).
- KRYS TTM SGA is now -80685.83% below its all-time high of -$1.15 million.
Performance
KRYS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
KRYS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.5% | +20.1% | -1025.1% |
| 3 y3 years | +181.5% | +30.2% | -1295.1% |
| 5 y5 years | +1658.5% | +30.2% | -1295.1% |
KRYS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +181.5% | at high | +143.2% | -106.4% | +25.4% |
| 5 y | 5-year | at high | +1658.5% | at high | +1633.4% | -636.0% | +25.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | <-9999.0% | +25.4% |
Krystal Biotech Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $113.69 M(+15.5%) | $31.29 M(+9.0%) | $113.69 M(+6.1%) |
| Sep 2024 | - | $28.71 M(+3.9%) | $107.16 M(+4.9%) |
| Jun 2024 | - | $27.63 M(+6.0%) | $102.14 M(+1.7%) |
| Mar 2024 | - | $26.06 M(+5.2%) | $100.42 M(+2.1%) |
| Dec 2023 | $98.40 M(+26.6%) | $24.76 M(+4.5%) | $98.40 M(+0.8%) |
| Sep 2023 | - | $23.70 M(-8.5%) | $97.67 M(+4.0%) |
| Jun 2023 | - | $25.90 M(+7.8%) | $93.90 M(+9.4%) |
| Mar 2023 | - | $24.04 M(+0.0%) | $85.86 M(+10.5%) |
| Dec 2022 | $77.73 M(+92.5%) | $24.03 M(+20.5%) | $77.74 M(+16.8%) |
| Sep 2022 | - | $19.93 M(+11.6%) | $66.57 M(+18.4%) |
| Jun 2022 | - | $17.86 M(+12.3%) | $56.21 M(+16.7%) |
| Mar 2022 | - | $15.91 M(+23.6%) | $48.15 M(+19.2%) |
| Dec 2021 | $40.39 M(+168.1%) | $12.87 M(+34.4%) | $40.39 M(+25.2%) |
| Sep 2021 | - | $9.57 M(-2.3%) | $32.27 M(+18.3%) |
| Jun 2021 | - | $9.80 M(+20.2%) | $27.28 M(+31.2%) |
| Mar 2021 | - | $8.15 M(+71.7%) | $20.80 M(+38.0%) |
| Dec 2020 | $15.06 M | $4.75 M(+3.7%) | $15.06 M(+24.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $4.58 M(+38.2%) | $12.12 M(+34.7%) |
| Jun 2020 | - | $3.31 M(+36.9%) | $9.00 M(+22.3%) |
| Mar 2020 | - | $2.42 M(+34.1%) | $7.36 M(+13.8%) |
| Dec 2019 | $6.46 M(+55.6%) | $1.80 M(+23.9%) | $6.46 M(+6.4%) |
| Sep 2019 | - | $1.46 M(-13.0%) | $6.08 M(+7.0%) |
| Jun 2019 | - | $1.67 M(+9.6%) | $5.68 M(+15.2%) |
| Mar 2019 | - | $1.53 M(+7.8%) | $4.93 M(+18.5%) |
| Dec 2018 | $4.16 M(+165.7%) | $1.42 M(+33.9%) | $4.16 M(+32.0%) |
| Sep 2018 | - | $1.06 M(+14.5%) | $3.15 M(+11.3%) |
| Jun 2018 | - | $924.00 K(+22.1%) | $2.83 M(+30.1%) |
| Mar 2018 | - | $757.00 K(+84.6%) | $2.17 M(+39.1%) |
| Dec 2017 | $1.56 M(+289.1%) | $410.00 K(-44.4%) | $1.56 M(+14.0%) |
| Sep 2017 | - | $738.00 K(+174.3%) | $1.37 M(+92.0%) |
| Jun 2017 | - | $269.00 K(+84.2%) | $714.00 K(+60.4%) |
| Mar 2017 | - | $146.00 K(-33.0%) | $445.00 K(+48.8%) |
| Dec 2016 | $402.00 K | $218.00 K(+169.1%) | $299.00 K(+269.1%) |
| Sep 2016 | - | $81.00 K | $81.00 K |
FAQ
- What is Krystal Biotech annual SGA?
- What is the all time high annual SGA for Krystal Biotech?
- What is Krystal Biotech annual SGA year-on-year change?
- What is Krystal Biotech quarterly SGA?
- What is the all time high quarterly SGA for Krystal Biotech?
- What is Krystal Biotech quarterly SGA year-on-year change?
- What is Krystal Biotech TTM SGA?
- What is the all time high TTM SGA for Krystal Biotech?
- What is Krystal Biotech TTM SGA year-on-year change?
What is Krystal Biotech annual SGA?
The current annual SGA of KRYS is $113.69 M
What is the all time high annual SGA for Krystal Biotech?
Krystal Biotech all-time high annual SGA is $113.69 M
What is Krystal Biotech annual SGA year-on-year change?
Over the past year, KRYS annual SGA has changed by +$15.29 M (+15.53%)
What is Krystal Biotech quarterly SGA?
The current quarterly SGA of KRYS is $31.29 M
What is the all time high quarterly SGA for Krystal Biotech?
Krystal Biotech all-time high quarterly SGA is $31.29 M
What is Krystal Biotech quarterly SGA year-on-year change?
Over the past year, KRYS quarterly SGA has changed by +$5.23 M (+20.07%)
What is Krystal Biotech TTM SGA?
The current TTM SGA of KRYS is -$929.04 M
What is the all time high TTM SGA for Krystal Biotech?
Krystal Biotech all-time high TTM SGA is -$1.15 M
What is Krystal Biotech TTM SGA year-on-year change?
Over the past year, KRYS TTM SGA has changed by -$1.03 B (-1025.12%)